Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-16-Speech-3-195-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-02-16"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"ro"^^xsd:language2
lpv:document identification number	"en.20110216.11.3-195-000"2
lpv:hasSubsequent	lp_eu:2011-02-16-Speech-3-196-0002
lpv:speaker	lp:George Becali2
lpv:spokenAs	member; INTA (2009-07-16--2012-01-18)3 member; Delegation to the Euronest Parliamentary Assembly (2009-09-16--2012-12-18)3 substitute; AGRI (2009-07-16--2012-01-18)3 member; NA (2009-07-14--2012-12-18)3 unknown; Partidul România Mare (2009-07-14--2012-12-18)3 member; Delegation to the EU-Armenia, EU-Azerbaijan and EU-Georgia Parliamentary Cooperation Committees (2009-09-16--2012-12-18)3
lpv:translated text	"I voted for this report as European citizens are becoming increasingly concerned about the quality and safety of medicines. Patients must be absolutely certain that the medicines they are taking are actually the medicines they expect to take. The use of falsified medicines may cause the treatment to fail and jeopardise lives. I think, as the rapporteur also does, that falsifying medicines is a criminal act which deprives patients of the medical treatment they require and harms their health, even resulting in death in some cases. For this reason, the directive’s first and most important objective should be to protect public health against falsified medicines. The level of public awareness also needs to be raised about the risks of buying medicines via the Internet. We must guarantee patients that they can recognise websites which comply with the relevant legislation. A directive intended to combat the falsification of medicines without targeting the Internet, which is the largest distribution channel, cannot be justified to the public."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph